Pengaruh Ukuran Perusahaan, Likuiditas, dan Perataan Laba Terhadap Kualitas Laba
Jurnal Akuntansi Bisnis · 06.09.2021 · 19 (2) · 235
DOI: 10.24167/jab.v19i2.3671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Akuntansi Bisnis, online erschienen am 06.09.2021. Verfasst von Fifi Devi Yoanita und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Earning s is a component of financial statements that describes the level of profitability of a company. The earning information listed on the financial statements should be of quality because investors can use profits to assess the company's future performance. This research aims to determine the influence of company size, liquidity, and income smoothing on earning quality in transportation sub-sector companies listed on the Indonesia Stock Exchange for the period 2015-2019. T o collect samples, this study uses purposive sampling which result in 45 firm observations. The data analysis technique used is multiple linear regression analysis. The result s showed that company's size, liquidity, and income smoothing have significant positive effect s on earning quality. In particular, the size of the company and income smoothing partially have significant positive effect s on earning quality. Meanwhile, liquidity has no effect on earning quality.
Zitieren
APA
Yoanita, F. D., & Khairunnisa, K. (2021). Pengaruh Ukuran Perusahaan, Likuiditas, dan Perataan Laba Terhadap Kualitas Laba. Jurnal Akuntansi Bisnis, 19(2), 235. https://doi.org/10.24167/jab.v19i2.3671
Vancouver
Yoanita FD, Khairunnisa K. Pengaruh Ukuran Perusahaan, Likuiditas, dan Perataan Laba Terhadap Kualitas Laba. Jurnal Akuntansi Bisnis. 2021;19(2):235. doi:10.24167/jab.v19i2.3671
BibTeX
@article{Yoanita2021,
author = {Yoanita, Fifi Devi and Khairunnisa, Khairunnisa},
title = {Pengaruh Ukuran Perusahaan, Likuiditas, dan Perataan Laba Terhadap Kualitas Laba},
journal = {Jurnal Akuntansi Bisnis},
year = {2021},
volume = {19},
number = {2},
pages = {235},
doi = {10.24167/jab.v19i2.3671}
}
EUVIMED